HopeStage
Back to all studies
RecruitingNCT07439744

EPA omega-3 for depressive symptoms in people with obesity

About this titleRead the official source — NCT07439744

This study assesses depression symptoms.

Placebo comparisonAges 18–54Taiwan
The study in practice

Understand this study

What is this study about?

This study assesses depression symptoms.

Who could participate?

Listed age limits: 18 years to 54 years.

Listed locations
TaichungSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: March 1, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
50
Sponsor
National Science and Technology Council, Taiwan
Sponsor type
Unknown or unclear
Study type
Other
Intervention type
Dietary supplement
Locations
Taiwan
Age range
From 18 Years to 54 Years
Official registry ID
NCT07439744
Official title
Show the full official title

Effects of 12-week n-3 PUFA Treatment (EPA) on Depressive Symptoms in Overweight/Obese Depressed Subjects With Low n-3 PUFA Status: Relationship With Systemic Inflammation

Recruitment & locations

Currently recruiting

Taichung

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What is this study about?

This study assesses depression symptoms.

Who is behind this study?

The study sponsor is National Science and Technology Council, Taiwan.

Who can participate?

Listed age limits: 18 years to 54 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies